method for controlling obesity in a mammalian patient in need of such treatment, method for treating obesity in a diabetic human patient and being treated with a diabetes drug prescribed, method for treating diabetes mellitus in a mammalian patient in need of such treatment for control of diabetes mellitus, method for treating or controlling hyperglycemia in a mammalian patient in need of such treatment, composition for use in the treatment of obesity, diabetes, or hyperglycemia as a disease, method for treating or controlling lipid disorders, hyperlipidemia, or low level of hdl in a mammalian patient in need thereof, method for treatment or control of hypercholesterolemia in a mammalian patient in need of such treatment, method for treatment or control of hyperglyceridemia in a mammalian patient in need of such treatment, method for treatment or control of dyslipidemia and / or low level of HDL cholesterol in a mammalian patient in need of such treatment, and method for treating ather

摘要

METHOD FOR OBESITY CONTROL IN A MAMMALIAN PATIENT REQUIRED SUCH TREATMENT, METHOD FOR OBESITY TREATMENT IN A DIABETIC HUMAN PATIENT FOR CONTROL OF DIABETES MELLITUS, METHOD FOR TREATMENT OR CONTROL OF HYPERGLYCEMIA IN A MAMMALIAN PATIENT REQUIRED SUCH TREATMENT, COMPOSITION FOR USE IN THE TREATMENT OF OBESITY, DIABETES, OR HYPERGLYCEMIA AS A TREATY OR DISEASE LOW HDL LEVEL IN A MAMMALLY PATIENT REQUIRED OF THE SAME, METHOD FOR TREATMENT OR CONTROL OF HYPERCOLESTEROLEMIA IN A MAMMALIAN PATIENT Dyslipidemia Control I / O LOW HDL CHOLESTEROL LEVEL IN A MAMMALLY PATIENT REQUIRED SUCH TREATMENT, AND A METHOD FOR TREATING ARTERIOSCLEROSIS IN A MAMMALLY PATIENT This is a method for treating obesity, diabetes, high blood levels. associated with hyperglycemia, lipid disorders, hyperglyceridemia, dyslipidemia and arteriosclerosis in mammals using anthocyanins, anthocyanidins, ursolic acid and / or betulinic acid. Compositions adapted for these treatments are also described.